Best Practices, LLC Home
View Cart Search the Site Contact Best Practices, LLC Press Room of Best Practices, LLC
ABOUT US RESEARCH & CONSULTING BENCHMARKING REPORTS BEST PRACTICE DATABASE RESEARCH & ADVISORY SERVICES BEST PRACTICES EXCELLENCE SERVICES
Industry > Pharmaceuticals > New Product Planning and Development

New Product Planning and Development Research

Managing Cross-Functional Teams for Pharmaceutical Product Commercialization Excellence 
The most comprehensive resource allocation system and the best econometric model will still produce sub-optimal results if key managers and personnel do not work together across functions, especially during product commercialization... (ID HR-63)
Companies Profiled: 3M Pharmaceuticals, Sanofi-aventis, aaiPharma, Amgen, more ...
Price: $4015.00


Building an Effective Regulatory Relationship with the FDA 
Though science remains the fundamental engine behind successful New Drug Applications, effective communication between pharmaceutical companies and the FDA at each stage of this process stands as a vital ingredient in securing approval for a new therapy... (ID OP-104)
Companies Profiled: Alcon, Amgen, AstraZeneca, Bayer, more ...
Price: $7000.00


Bolstering Product Portfolios: Resources, Structure and Process for Effective In-licensing Organizations 
Gain insight into how to structure in-licensing organizations, develop processes that facilitate the ability to identify the best opportunities and move smoothly from initial contact to binding agreement... (ID OP-93)
Companies Profiled: AstraZeneca, Sanofi-aventis, Bristol-Myers Squibb, Genentech, more ...
Price: $3328.00


Medical Affairs Excellence: Structuring, Aligning and Funding for Global Success 
In today's challenging healthcare environment, medical affairs' role has become even more crucial to pharmaceutical companies' success... (ID OP-97)
Companies Profiled: Amgen, Sanofi-aventis, Eli Lilly, AstraZeneca, more ...
Price: $4725.00


Profitable Partnerships: Developing Excellence in Alliances 
Competition to secure inlicensing deals for the most promising new compounds is increasing, and the balance of power between big Pharma companies and small biotechs in these deals is shifting... (ID OP-98)
Companies Profiled: Aderis, Atherogenics, Atrix, Bristol-Myers Squibb Medical Imaging, more ...
Price: $5776.00


Medical Affairs Resources, Structures & Trends 
Charged with building and maintaining physician relationships, pharmaceutical Medical Affairs organizations typically oversee several important functions -- including publications, KOL programs, grants and medical education (CME) -- that have been impacted in recent years by a call for increased transparency... (ID POP-228)
Companies Profiled: Amgen, Astellas, AstraZeneca Pharmaceuticals, Bayer Schering AG, more ...
Price: $4100.00


Best Practices for Internal Communications Regarding Brands & Disease State 
When a promising new pharmaceutical product fails to meet expectations, poor brand communications may be a contributing cause... (ID POP-229)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, Actelion, Boehringer Ingelheim, more ...
Price: $7400.00


Fixed Dose Combination Products: Successful Strategies for Developing and Bringing FDC Products to Market 
Fixed dose combination (FDC) products are becoming increasingly popular as they reduce the number of medications certain patients need to take while suffering from illness... (ID POP-232)
Companies Profiled: Abbott, Xanodyne Pharmaceuticals, Victory, Valeant, more ...
Price: $4100.00


Managing Market Planning for New Oncology Products 
Understand how leading pharmaceutical companies effectively manage market planning for oncology products during Phase II and Phase III... (ID PSM-205)
Price: $628.00


Pharmaceutical Brand Leadership: Getting There and Staying on Top 
Why do some pharmaceutical brands fail and others succeed? This study identifies exact factors driving some brands such as Celebrex and Lipitor to the front of the pack in their therapeutic classes and what kept these brands at #1... (ID PSM-210)
Companies Profiled: AstraZeneca, Sanofi-aventis, Abbott Laboratories, Amgen, more ...
Price: $1840.00


Best Practices in Utilizing Health Outcomes Data 
Optimizing the use of Health Outcomes data is vital to the success of biotechnology and pharmaceutical companies... (ID PSM-236)
Companies Profiled: Abbott, Alfred Mann Foundation, ASSESSmint, Baxter, more ...
Price: $4000.00


Educating the Marketplace to Support Successful Diabetes Product Launches 
The bio-pharmaceutical marketplace – including the diabetes therapeutic area – continues to evolve as new medicines and technologies create valuable market opportunities... (ID PSM-246)
Companies Profiled: GlaxoSmithKline , ARIAD, Pfizer, Integrated Communications Corp., more ...
Price: $8000.00


Driving Growth through New Product Planning and Strategic Alliances 
Drive overall growth through a well-managed portfolio by addressing current and long-term needs in your company's new product planning and strategic alliance systems... (ID SM-135)
Companies Profiled: Amgen, Eli Lilly, Janssen, Pfizer
Price: $5622.00


From Genes to Giants: Best Practices in Early-Stage Product Commercialization 
Long and costly product development cycles make it essential today for pharmaceutical companies to allocate resources to the development of compounds with the greatest potential market value... (ID SM-162)
Companies Profiled: Abbott, Allergan, Bayer, Boehringer-Ingelheim, more ...
Price: $5058.00


Using Institutional Patient Flow Maps to Optimize Psychiatric Treatment 
Create hospital-based initiatives that improve emergency care for psychiatric patients while potentially enhancing market share for psychiatric treatments... (ID SM-164)
Companies Profiled: Baylor University Medical Center, Detroit Receiving Hospital, Kona Community Hospital, Medical City Dallas Hospital, more ...
Price: $1892.00


Mapping Patient Flow to Better Manage Severe Hospital Infections and Sepsis 
Infections, and in particular the septic response to infections, are rising at an alarming rate in healthcare settings around the globe... (ID SM-165)
Companies Profiled: Amgen, AstraZeneca, Baxter Healthcare, Cooper Health System, more ...
Price: $1891.00


 


All contents copyright 1998-2012 Best Practices, LLC (919) 403-0251
Site Map | Read our Privacy Policy and Copyright Information